The first report of pregnancies following blastocyst automated vitrification in Europe.
Automated vitrification
Blastocyst
Cryopreservation
Gavi®
Pregnancy
Journal
Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
16
02
2019
revised:
30
04
2019
accepted:
07
05
2019
pubmed:
12
5
2019
medline:
6
2
2020
entrez:
12
5
2019
Statut:
ppublish
Résumé
Embryo cryopreservation is a valuable technique in assisted reproductive technology (ART) that increases cumulative pregnancy rates and allows postponement of embryo transfer in patients with undesirable uterine or clinical conditions. Although vitrification has been considered the most efficient method to freeze oocytes and embryos, it is time-consuming and highly operator-dependent. Gavi® is the first semi-automated machine for vitrification capable of controlling crucial variables such as temperature, volume, concentration and exposure time during the vitrification process. We report the first two pregnancies obtained with blastocysts cryopreserved with the Gavi® semi-automated vitrification system in Europe. These outcomes suggest that the utilization of semi-automated vitrification may contribute to improve the outcomes and laboratory logistics of fertility clinics.
Identifiants
pubmed: 31077870
pii: S2468-7847(19)30109-6
doi: 10.1016/j.jogoh.2019.05.012
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
537-540Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.